Statistics

Total Visits

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial49

Select a period of time:

Number of views in the range

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial11

Views

Views
August 20251
September 20257
October 20252
November 20251
December 20250
January 20260
February 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Brazil3
United Kingdom1
 

Top cities views

Views
Dallas6
Curitiba1
Guarulhos1
Ipatinga1